If effective, Johnson & Johnson's one-dose vaccine could quickly help large swaths of the United States develop immunity to COVID-19. That would be a game changer.
Only 21 of the 1.9 million people who got a shot during the initial COVID-19 vaccine rollout experienced severe allergic reactions. The benefits outweigh the risks, CDC experts say.